Drug Shortage Report for MYLAN-EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE
| Report ID | 113424 |
| Drug Identification Number | 02461412 |
| Brand name | MYLAN-EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE |
| Common or Proper name | EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE |
| Company Name | MYLAN PHARMACEUTICALS ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | EFAVIRENZ EMTRICITABINE TENOFOVIR DISOPROXIL FUMARATE |
| Strength(s) | 600MG 200MG 300MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 30BT |
| ATC code | J05AR |
| ATC description | DIRECT ACTING ANTIVIRALS |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | 2020-07-08 |
| Actual start date | |
| Estimated end date | 2020-09-08 |
| Actual end date | 2020-05-19 |
| Shortage status | Avoided shortage |
| Updated date | 2020-07-09 |
| Company comments | short dated inventory |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
| Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v7 | 2020-07-09 | French | Compare |
| v6 | 2020-07-09 | English | Compare |
| v5 | 2020-07-09 | English | Compare |
| v4 | 2020-05-12 | French | Compare |
| v3 | 2020-05-12 | English | Compare |
| v2 | 2020-04-29 | French | Compare |
| v1 | 2020-04-29 | English | Compare |
Showing 1 to 7 of 7